chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vertebral end plate inflammation, X-ray
Clinical narrative: discogenic marrow changes; degenerative disc disease; osteoarthritis; chills; low grade fever; Severe backache/Severe low back pain that radiated to right hip; A spontaneous report was received from a consumer concerning a 80 year old, female patient who developed Severe backache/Severe low back pain that radiated to right hip, discogenic marrow changes, degenerative disc disease, osteoarthritis, fever, and chills.     The patient's medical history included blood clots, hypertension and anxiety.  Products known to have been used by the patient, within two weeks prior to the event, included clonazepam, apixaban, lisinopril, and oxycodone hydrochloride/oxycodone terephthalate.     On 28-JAN-2021, approximately four days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 012M20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. It was planned for patient to receive their second dose on 03 Mar 2021.   On an unspecified date post vaccination, patient developed low grade fever and chills. On 01 Feb 2021, four days post vaccination, the patient developed severe backache described as severe low back pain that radiated to right hip. An ambulance was called and patient was transported to an emergency room (ER) where an X-ray was done. Patient was then sent home and told to follow-up with her primary care physician (PCP) who referred to a pain clinic. A magnetic resonance imaging (MRI) revealed osteoarthritis, degenerative disc disease and discogenic marrow changes. The patient is unable to have steroid injections because of her use of an anticoagulant.  Treatment information was unknown.    There was no change planned to the dosing schedule of mRNA-1273 in response to the event(s).  The events Severe backache/Severe low back pain that radiated to right hip, discogenic marrow changes, degenerative disc disease, and osteoarthritis were considered not recovered/not resolved.   The outcome of events fever and chills, was unknown.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling cold, Headache, Pain in extremity
Clinical narrative: arm sore; diarrhea; cold and shaking could not warm up; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), HEADACHE (headache), DIARRHOEA (diarrhea) and FEELING COLD (cold and shaking could not warm up) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O38K2OA) for COVID-19 vaccination.     Concomitant products included centroid for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm sore), HEADACHE (headache), DIARRHOEA (diarrhea) and FEELING COLD (cold and shaking could not warm up). On 05-Feb-2021, DIARRHOEA (diarrhea) had resolved. At the time of the report, PAIN IN EXTREMITY (arm sore) had not resolved and HEADACHE (headache) and FEELING COLD (cold and shaking could not warm up) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included : ginger ale, rice and soup, salting crackers, tea, banana and Tylenol
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysstasia, Fatigue, Headache, Influenza like illness
Clinical narrative: Could barely stand; feels like she has the flu; feel really sick; body was fatigued; muscles were so achy, body aches; fever; Chills; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (feel really sick), DYSSTASIA (Could barely stand), INFLUENZA LIKE ILLNESS (feels like she has the flu), FATIGUE (body was fatigued) and MYALGIA (muscles were so achy, body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced MALAISE (feel really sick), DYSSTASIA (Could barely stand), INFLUENZA LIKE ILLNESS (feels like she has the flu), FATIGUE (body was fatigued), MYALGIA (muscles were so achy, body aches), PYREXIA (fever), CHILLS (Chills) and HEADACHE (headache). At the time of the report, MALAISE (feel really sick), DYSSTASIA (Could barely stand), INFLUENZA LIKE ILLNESS (feels like she has the flu), MYALGIA (muscles were so achy, body aches), PYREXIA (fever) and CHILLS (Chills) outcome was unknown and FATIGUE (body was fatigued) and HEADACHE (headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Headache added, outcome of fatigue updated.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Pyrexia
Clinical narrative: Could barely stand; feels like she has the flu; feel really sick; body was fatigued; muscles were so achy, body aches; fever; Chills; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (feel really sick), DYSSTASIA (Could barely stand), INFLUENZA LIKE ILLNESS (feels like she has the flu), FATIGUE (body was fatigued) and MYALGIA (muscles were so achy, body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced MALAISE (feel really sick), DYSSTASIA (Could barely stand), INFLUENZA LIKE ILLNESS (feels like she has the flu), FATIGUE (body was fatigued), MYALGIA (muscles were so achy, body aches), PYREXIA (fever), CHILLS (Chills) and HEADACHE (headache). At the time of the report, MALAISE (feel really sick), DYSSTASIA (Could barely stand), INFLUENZA LIKE ILLNESS (feels like she has the flu), MYALGIA (muscles were so achy, body aches), PYREXIA (fever) and CHILLS (Chills) outcome was unknown and FATIGUE (body was fatigued) and HEADACHE (headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Headache added, outcome of fatigue updated.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Gingivitis, Peripheral swelling, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Arm was red; swollen; gum infection; injection site is very red; injection site is swollen; This spontaneous case was reported by a health care professional and describes the occurrence of ERYTHEMA (Arm was red), PERIPHERAL SWELLING (swollen), VACCINATION SITE ERYTHEMA (injection site is very red), VACCINATION SITE SWELLING (injection site is swollen) and GINGIVITIS (gum infection) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site is very red) and VACCINATION SITE SWELLING (injection site is swollen). On an unknown date, the patient experienced ERYTHEMA (Arm was red), PERIPHERAL SWELLING (swollen) and GINGIVITIS (gum infection). The patient was treated with CLINDAMYCIN at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Arm was red), PERIPHERAL SWELLING (swollen), VACCINATION SITE ERYTHEMA (injection site is very red), VACCINATION SITE SWELLING (injection site is swollen) and GINGIVITIS (gum infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Malaise, Polydipsia
Clinical narrative: felt very thirsty; wasnt feeling great felt sick; chills, had a lot of chills; fatigue, felt very tired; unsure if she had a temperature it would be a low-grade fever; loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of POLYDIPSIA (felt very thirsty), MALAISE (wasnt feeling great felt sick), CHILLS (chills, had a lot of chills), FATIGUE (fatigue, felt very tired) and PYREXIA (unsure if she had a temperature it would be a low-grade fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POLYDIPSIA (felt very thirsty), MALAISE (wasnt feeling great felt sick), CHILLS (chills, had a lot of chills), FATIGUE (fatigue, felt very tired) and DECREASED APPETITE (loss of appetite). 27-Jan-2021, the patient experienced PYREXIA (unsure if she had a temperature it would be a low-grade fever). At the time of the report, POLYDIPSIA (felt very thirsty), MALAISE (wasnt feeling great felt sick), CHILLS (chills, had a lot of chills), FATIGUE (fatigue, felt very tired), PYREXIA (unsure if she had a temperature it would be a low-grade fever) and DECREASED APPETITE (loss of appetite) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-035834 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Feb-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: felt very thirsty; wasnt feeling great felt sick; chills, had a lot of chills; fatigue, felt very tired; unsure if she had a temperature it would be a low-grade fever; loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of POLYDIPSIA (felt very thirsty), MALAISE (wasnt feeling great felt sick), CHILLS (chills, had a lot of chills), FATIGUE (fatigue, felt very tired) and PYREXIA (unsure if she had a temperature it would be a low-grade fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POLYDIPSIA (felt very thirsty), MALAISE (wasnt feeling great felt sick), CHILLS (chills, had a lot of chills), FATIGUE (fatigue, felt very tired) and DECREASED APPETITE (loss of appetite). 27-Jan-2021, the patient experienced PYREXIA (unsure if she had a temperature it would be a low-grade fever). At the time of the report, POLYDIPSIA (felt very thirsty), MALAISE (wasnt feeling great felt sick), CHILLS (chills, had a lot of chills), FATIGUE (fatigue, felt very tired), PYREXIA (unsure if she had a temperature it would be a low-grade fever) and DECREASED APPETITE (loss of appetite) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-035834 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Feb-2021: No specific follow-up information recorded.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for COVID-19 after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19 after vaccination) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced COVID-19 (tested positive for COVID-19 after vaccination). At the time of the report, COVID-19 (tested positive for COVID-19 after vaccination) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter  No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash macular, Swelling
Clinical narrative: Itching at the injection site; Redness at the injection site; Blotches at the injection site; Swelling at the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching at the injection site), ERYTHEMA (Redness at the injection site), RASH MACULAR (Blotches at the injection site) and SWELLING (Swelling at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PRURITUS (Itching at the injection site), ERYTHEMA (Redness at the injection site), RASH MACULAR (Blotches at the injection site) and SWELLING (Swelling at the injection site). On 17-Feb-2021, PRURITUS (Itching at the injection site), ERYTHEMA (Redness at the injection site), RASH MACULAR (Blotches at the injection site) and SWELLING (Swelling at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: diagnosed with covid19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosed with covid19) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (diagnosed with covid19). At the time of the report, COVID-19 (diagnosed with covid19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 test positive: Diagnosed with covid19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported No treatment information was provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site rash
Clinical narrative: injection site redness; injection site rash; sore arm again; Arm sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore), PAIN IN EXTREMITY (sore arm again), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE RASH (injection site rash) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm sore). On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm again) and VACCINATION SITE RASH (injection site rash). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness). At the time of the report, PAIN IN EXTREMITY (Arm sore), PAIN IN EXTREMITY (sore arm again) and VACCINATION SITE RASH (injection site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products information was not reported.  Treatment information was not provided.   Reporter did not allow further contact
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HEADACHE (headache). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) at a dose of 1 dosage form. On 12-Feb-2021, HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: NNI
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema
Clinical narrative: arm started to itch again and was red again; small little red itchy spots; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (small little red itchy spots) and VACCINATION SITE ERYTHEMA (arm started to itch again and was red again) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PRURITUS (small little red itchy spots). On 08-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm started to itch again and was red again). At the time of the report, PRURITUS (small little red itchy spots) had resolved and VACCINATION SITE ERYTHEMA (arm started to itch again and was red again) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment Arthritis Strength Tylenol and prescription strength ibuprofen along with using an ice pack and cold compress
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Influenza like illness, Injection site pain, Pain
Clinical narrative: flu like symptoms; aches and pains; fatigue; discomfort; injection arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (aches and pains), FATIGUE (fatigue), DISCOMFORT (discomfort) and INJECTION SITE PAIN (injection arm hurt) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included TAMSULOSIN, LOSARTAN, AMLODIPINE and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN (aches and pains), FATIGUE (fatigue), DISCOMFORT (discomfort) and INJECTION SITE PAIN (injection arm hurt). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). The patient was treated with ACETAMINOPHEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 09-Feb-2021, INJECTION SITE PAIN (injection arm hurt) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (aches and pains), FATIGUE (fatigue) and DISCOMFORT (discomfort) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Action taken with mRNA-1273 in response to the events was unknown.  On 9 Feb 2021 the outcome of events, injection arm hurt was resolved. The outcome of events, flu-like symptoms, aches and pains, fatigue, discomfort was unknown.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Short-term memory loss.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath). At the time of the report, DYSPNOEA (shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient had a history of COL. patient was on Oxygen therapy for symptoms.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Limb discomfort, Pain in extremity
Clinical narrative: He cant lift the arm because of the pain; Back is hurting; Can't use arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (He cant lift the arm because of the pain), BACK PAIN (Back is hurting) and LIMB DISCOMFORT (Can't use arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 316139 Wasn't sure) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (He cant lift the arm because of the pain), BACK PAIN (Back is hurting) and LIMB DISCOMFORT (Can't use arm). At the time of the report, PAIN IN EXTREMITY (He cant lift the arm because of the pain), BACK PAIN (Back is hurting) and LIMB DISCOMFORT (Can't use arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was included vitamins.
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: soreness after first shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness after first shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (soreness after first shot). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN (soreness after first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-038612 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Feb-2021: Additional information received
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral coldness
Clinical narrative: Experiencing an ice cold right hand with tingling fingertips; Tingling fingertips; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (Experiencing an ice cold right hand with tingling fingertips) and PARAESTHESIA (Tingling fingertips) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PERIPHERAL COLDNESS (Experiencing an ice cold right hand with tingling fingertips) and PARAESTHESIA (Tingling fingertips). At the time of the report, PERIPHERAL COLDNESS (Experiencing an ice cold right hand with tingling fingertips) and PARAESTHESIA (Tingling fingertips) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Pruritus, Vaccination site bruising, Vaccination site reaction
Clinical narrative: Vaccination site bruise; It is hard; Itchy; Large red spot; Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE BRUISING (Vaccination site bruise), INDURATION (It is hard), PRURITUS (Itchy) and ERYTHEMA (Large red spot) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CITALOPRAM, VALPROATE SEMISODIUM (DIVALPROEX), PRAVASTATIN and METOPROLOL for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE REACTION (Covid arm), INDURATION (It is hard) and PRURITUS (Itchy). 27-Feb-2021, the patient experienced ERYTHEMA (Large red spot). On an unknown date, the patient experienced VACCINATION SITE BRUISING (Vaccination site bruise). At the time of the report, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE BRUISING (Vaccination site bruise), INDURATION (It is hard), PRURITUS (Itchy) and ERYTHEMA (Large red spot) outcome was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site swelling
Clinical narrative: Vaccination side was swollen this morning; Seemed to be experiencing fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Vaccination side was swollen this morning) and FATIGUE (Seemed to be experiencing fatigue) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 042120A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Diabetes mellitus and Arthritis.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Vaccination side was swollen this morning) and FATIGUE (Seemed to be experiencing fatigue). At the time of the report, VACCINATION SITE SWELLING (Vaccination side was swollen this morning) and FATIGUE (Seemed to be experiencing fatigue) had resolved.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Head discomfort, Headache, Nausea
Clinical narrative: Uncontrollable shaking; Couldn't lift up head; 103-106 fever; Chills; Nausea; Tired; Little rash with little bumps; Worse headache that he has ever had in his life; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Uncontrollable shaking), HEAD DISCOMFORT (Couldn't lift up head), PYREXIA (103-106 fever), CHILLS (Chills) and NAUSEA (Nausea) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Uncontrollable shaking), HEAD DISCOMFORT (Couldn't lift up head), PYREXIA (103-106 fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Tired), VACCINATION SITE RASH (Little rash with little bumps) and HEADACHE (Worse headache that he has ever had in his life). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, TREMOR (Uncontrollable shaking), HEAD DISCOMFORT (Couldn't lift up head), PYREXIA (103-106 fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Tired) and VACCINATION SITE RASH (Little rash with little bumps) had not resolved and HEADACHE (Worse headache that he has ever had in his life) had resolved.            Wife of a patient reported that her husband received the 2nd dose on 24FEB2021 and on an unknown date reported 103-106 fever (lasted a few days), uncontrollable shaking, chills, nausea, tired, couldn't lift up head, worse headache that he has ever had in his life (ended), little rash with little bumps (ongoing). Patient said that she got her second vaccine shot and she still has side-effects   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: TCR received-Reaction outcome information provided.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vaccination site rash
Clinical narrative: Uncontrollable shaking; Couldn't lift up head; 103-106 fever; Chills; Nausea; Tired; Little rash with little bumps; Worse headache that he has ever had in his life; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Uncontrollable shaking), HEAD DISCOMFORT (Couldn't lift up head), PYREXIA (103-106 fever), CHILLS (Chills) and NAUSEA (Nausea) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Uncontrollable shaking), HEAD DISCOMFORT (Couldn't lift up head), PYREXIA (103-106 fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Tired), VACCINATION SITE RASH (Little rash with little bumps) and HEADACHE (Worse headache that he has ever had in his life). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, TREMOR (Uncontrollable shaking), HEAD DISCOMFORT (Couldn't lift up head), PYREXIA (103-106 fever), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Tired) and VACCINATION SITE RASH (Little rash with little bumps) had not resolved and HEADACHE (Worse headache that he has ever had in his life) had resolved.            Wife of a patient reported that her husband received the 2nd dose on 24FEB2021 and on an unknown date reported 103-106 fever (lasted a few days), uncontrollable shaking, chills, nausea, tired, couldn't lift up head, worse headache that he has ever had in his life (ended), little rash with little bumps (ongoing). Patient said that she got her second vaccine shot and she still has side-effects   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: TCR received-Reaction outcome information provided.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus
Clinical narrative: Itchy; Red spot moved toward the elbow; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), PAIN IN EXTREMITY (Sore arm) and ERYTHEMA (Red spot moved toward the elbow) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 26-Feb-2021, the patient experienced ERYTHEMA (Red spot moved toward the elbow). On 27-Feb-2021, the patient experienced PRURITUS (Itchy). At the time of the report, PRURITUS (Itchy), PAIN IN EXTREMITY (Sore arm) and ERYTHEMA (Red spot moved toward the elbow) was resolving.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pruritus, Rash
Clinical narrative: Itching; Rash on both hands and knees; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PRURITUS (Itching) and RASH (Rash on both hands and knees) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). On 26-Feb-2021, the patient experienced PRURITUS (Itching) and RASH (Rash on both hands and knees). On 18-Feb-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, PRURITUS (Itching) and RASH (Rash on both hands and knees) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at injection site) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). At the time of the report, VACCINATION SITE RASH (Rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Tinnitus
Clinical narrative: Ringing in ears, has come and gone - in the right ear - has happened 2-3 days after the vaccine and has been persistent; Mild headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in ears, has come and gone - in the right ear - has happened 2-3 days after the vaccine and has been persistent) and HEADACHE (Mild headache) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Ringing in ears, has come and gone - in the right ear - has happened 2-3 days after the vaccine and has been persistent) and HEADACHE (Mild headache). At the time of the report, TINNITUS (Ringing in ears, has come and gone - in the right ear - has happened 2-3 days after the vaccine and has been persistent) had not resolved and HEADACHE (Mild headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received his first dose of the Moderna vaccine a month ago, in his upper left arm. About 2-3 days later, he experienced ringing in his ears which has come and gone. The ringing was specifically in his right ear. He did mention that he had ringing in his ears in the past but stated that it has been persistent since he received the vaccine. He also experienced a mild headache.
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Hypoaesthesia, Paraesthesia
Clinical narrative: cold sensation on nose; tingling sensation on face and tongue; had a feeling on face like getting Novacaine, It did not stop me from doing my daily activities; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (cold sensation on nose), PARAESTHESIA (tingling sensation on face and tongue) and HYPOAESTHESIA (had a feeling on face like getting Novacaine, It did not stop me from doing my daily activities) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 15-Feb-2021, the patient experienced FEELING COLD (cold sensation on nose), PARAESTHESIA (tingling sensation on face and tongue) and HYPOAESTHESIA (had a feeling on face like getting Novacaine, It did not stop me from doing my daily activities). On 15-Feb-2021, FEELING COLD (cold sensation on nose), PARAESTHESIA (tingling sensation on face and tongue) and HYPOAESTHESIA (had a feeling on face like getting Novacaine, It did not stop me from doing my daily activities) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient stated that she got her 1st moderna dose on 15Feb2021 to right dominant hand via IM injection. Within minutes of getting shot I felt cold sensation on nose and tingling sensation on face and tongue it dissipated and resolved same day. she had a feeling on face like getting Novacaine. It did not stop her from doing her daily activities.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Diarrhoea, Flatulence
Clinical narrative: Heavy diarrhea; Bloating; Shooting gas pain from stomach; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Heavy diarrhea), ABDOMINAL DISTENSION (Bloating) and FLATULENCE (Shooting gas pain from stomach) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007m20a) for COVID-19 vaccination.     No medical history was reported.  The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN, FINASTERIDE and TAMSULOSIN for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (Heavy diarrhea), ABDOMINAL DISTENSION (Bloating) and FLATULENCE (Shooting gas pain from stomach). At the time of the report, DIARRHOEA (Heavy diarrhea), ABDOMINAL DISTENSION (Bloating) and FLATULENCE (Shooting gas pain from stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Fever; Swelling; Redness; Pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PYREXIA (Fever), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain) and FATIGUE (Fatigue). On 25-Feb-2021, PYREXIA (Fever) had resolved. At the time of the report, VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Caller states that she received the 1st dose of the moderna 23Feb2021. Fever the first 2 days.Swollen and red at first, it went down now. Had very little use of the right use, was given IM in the shoulder and had pain all the way down to the arm which subsided but its still too painful to move it. She is fatigued too.
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Had blurry vision for 2 to 2.5 hours; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Had blurry vision for 2 to 2.5 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced VISION BLURRED (Had blurry vision for 2 to 2.5 hours). On 28-Feb-2021, VISION BLURRED (Had blurry vision for 2 to 2.5 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated that she got her first vaccine yesterday, had blurry vision for 2 to 2.5 hours, it had started right after the shot and it lasted the whole 2 hours. Patient said she's fine now.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: High fever of 103 degrees; Had the chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High fever of 103 degrees) and CHILLS (Had the chills) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (High fever of 103 degrees) and CHILLS (Had the chills). At the time of the report, PYREXIA (High fever of 103 degrees) and CHILLS (Had the chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Pyrexia: 103 degree (plane angle) (High) 103 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was vaccinated on 3Feb2021. On 4Feb2021 he had high fever of 103 degrees. Also he had chills.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: red mark around the vaccine site and it itches; red mark around the vaccine site and it itches; This spontaneous case was reported by a consumer and describes the occurrence of   in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.            patient called in stating she received her 2nd vaccine 28Feb2021 and had a red mark around the vaccine site and it itches
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Vaccination site erythema, Vaccination site mass, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: lump; itching; swelling; bright red coloring; Incorrect route of product administration; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Incorrect route of product administration) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Implant) 1 dosage form. On 12-Feb-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Incorrect route of product administration). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Incorrect route of product administration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Implant) was unknown.       Patient received the first dose of moderna vaccine on 12Feb201 and had a reaction. 4 days after the shot had itching on the arm of the injection. 6 or 7 days after noticed swelling and discovered the was a lump there, and bright red coloring. This symptoms were better,the swelling was better and itching was gone.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.